NCT00850434

Brief Summary

The purpose of this study is to compare a modified AutoSet algorithm running on research hardware versus the traditional AutoSet algorithm running on an S7 AutoSet Spirit. The study will determine if the modified AutoSet algorithm reacts appropriately to obstructive apnoeas and hypopnoeas and provides suitable levels of positive airway pressure compared to the S7 AutoSet Spirit. The hypothesis is that the modified AutoSet algorithm will be more efficacious than the traditional AutoSet algorithm

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2005

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2005

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2008

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2008

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 25, 2009

Completed
Last Updated

February 4, 2021

Status Verified

February 1, 2021

Enrollment Period

2.8 years

First QC Date

February 24, 2009

Last Update Submit

February 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Physiological sleep signals including EEG, Sp02, respiratory effort and nasal flow, will be recorded, analysed and reported in the form of a series of indices, which are the outcome variables of the study.

    sleep signals taken from overnight polysomnography recordings

    Two consecutive nights

Study Arms (2)

modified autoset

EXPERIMENTAL

the modified AutoSet responds to different breathing patterns than the standard AutoSet, to treat OSA. Participants in this arm will trial the modified AutoSet for one night, and the standard AutoSet for one night, in a randomised order

Device: Modified AutoSet AlgorithmDevice: Standard AutoSet Algorithm

standard AutoSet

ACTIVE COMPARATOR

The standard autoset treat OSA by using pressure increases to overcome abnormal breathing patterns. Patients in this arm will use the standard AutoSet for one night and the modified AutoSet for one night, in a randomised order

Device: Modified AutoSet AlgorithmDevice: Standard AutoSet Algorithm

Interventions

The modified AutoSet algorithm responds to more patient "non-normal" flow types than the standard AutoSet algorithm

Also known as: Enhanced AutoSet algorithm
modified autosetstandard AutoSet

The standard AutoSet used for treatment of OSA

modified autosetstandard AutoSet

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PSG-confirmed diagnosis of OSA, showing an apnoea-hypopnoea index (AHI) of at least 15 events/hr and an obstructive apnoea index (OAI) of at least 5 events/hr.
  • On CPAP therapy (fixed pressure or autoCPAP) for at least 1 month.
  • Using a ResMed mask (this requirement applies only to phase 2 of the trial) without significant discomfort for at least 2 weeks.
  • Age between 18 and 70 years.
  • Written informed consent.

You may not qualify if:

  • Unstable medical condition, including unstable angina, myocardial infarction within previous 6 months, cardiac failure NYHA grades III and IV, epilepsy, psychiatric disturbance.
  • Respiratory insufficiency, defined as arterial CO2 greater than 50 mm Hg during the daytime or arterial oxygen saturation less than 90% when asleep and breathing room air on effective CPAP therapy.
  • Recent severe epistaxis.
  • History of spontaneous pneumothorax.
  • History of regurgitation of gastric contents during sleep.
  • Unable to give written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep & Chest Disorders Centre

Sydney, New South Wales, 2000, Australia

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Klaus Schindhelm, PhD

    ResMed / University of NSW

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2009

First Posted

February 25, 2009

Study Start

November 1, 2005

Primary Completion

September 1, 2008

Study Completion

November 1, 2008

Last Updated

February 4, 2021

Record last verified: 2021-02

Locations